Additional file 1: Table S1. of Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
2018
Treatment costs according to type of first-line treatment received by patients with EGFR Mutâ +â NSCLC. (DOCX 15 kb)
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI